[1] 杨明会,李军艳,刘毅.系统论引领帕金森病治疗思路[J].医学与哲学,2009,30(2):3-5.
[2] 杨明会,窦永起,刘毅,等.抑颤汤治疗帕金森病临床对照观察[J].中国中西医结合急救杂志,2002,9(5):256-257.
[3] 李军艳,杨明会,窦永起,等. 补肾活血饮治疗原发性帕金森病的疗效观察[J]. 解放军医学杂志, 2011,36(3):273-276.
[4] 杨明会,李敏,窦永起,等.补肾活血颗粒对帕金森病患者运动功能的影响:多中心、随机、双盲、安慰剂对照研究[J].中西医结合学报,2010,8(3):231-237.
[5] 李敏,杨明会,窦永起,等.补肾活血颗粒对帕金森病患者肱二头肌肌张力的影响[J].中药材,2011,34(3):490- 493.
[6] 李敏,杨明会,刘毅,等. 补肾活血颗粒对帕金森病患者四肢肌张力的影响[J].中华中医药杂志,2012,27(3):599- 601.
[7] 李敏,杨明会,刘毅,等. 补肾活血颗粒治疗帕金森病运动并发症临床研究[J].中华中医药杂志, 2011,26(6):1296-1299.
[8] 包新民,舒斯云.大鼠脑立体定位图谱[M].北京:人民卫生出版社,1991:49-59.
[9] 施新猷.医学动物实验方法 [M].北京:人民卫生出版社,1986:11.
[10] 卢文朋,栗世方. 大鼠脑组织灌注固定方法的改进[J].医学研究生学报,2014,27(6):627- 629
[11] Blum D, Torch S,Lambeng N,et al.Molecular pathways involved in the neurotoxicity of 6-OHDA,dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease[J]. Prog Neurobiol, 2001,65(2):135
[12] Deumens R, Blokland A, Priekaerts J. Modeling Parkinson's disease in rats: a evaluation of 6-OHDA lesions of the nigrostriatal pathway[J]. Exp Neurol,2002,175(2):303-317
[13] Vermes I,Steur EN,Reutrlingsperger C,et a1.Decreased concentration of annexin in parkinsonian cerebrospinal fluid:speculation on the underlying cause[J].Mov Disord,1999,14(6):1008-1010.
[14] Babu P P,Suzuki G,Ono Y,et al. Attenuation of ischemia and/or reperfusion injury during myocardial infarction using mild hypothermia in rats: an immunohistochemical study of bcl-2,bax,Bak and TUNEL[J].Pathol Int,2004,54(12):896-903.
[15] 屈二军,胡建业,陈兰英.细胞凋亡的机理与调节研究进展[J].现代医药卫生,2008,24(13):1995-1997.
[16] Duan X X, Ou J S, Li Y, et al. Dynamic expression of apoptosis related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis [J]. World J Gastroenterol,2005,11(30):4740- 4744.
[17] Martin L J. Neuronal cell death in nervous system development, disease, and injury[J].International Journal of Molecular Medicine, 2001,7(5):455.
[1]霍青 于亚萍.中药治疗帕金森病临床疗效的系统评价[J].环球中医药,2014,7(01):29.
HUO Qing,YU Ya ping..Systemically review of the clinical curative effect of Parkinsons disease treated with traditional Chinese medicine(TCM)[J].,2014,7(04):29.
[2]郭云霞,杨明会.中医药干预帕金森病实验研究进展[J].环球中医药,2013,6(10):773.
GUO Yun xia,YANG Ming hui..Animal experimental study progress of TCM intervention on Parkinsons disease[J].,2013,6(04):773.
[3]霍青,柳琳,李强,等.水木和宁方改善帕金森病患者生活质量的研究[J].环球中医药,2016,9(12):1553.[doi:10.3969/j.issn.1674-1749.2016.12.039]
[4]李婷 田金洲 秦斌 樊东升 刘建平 刘娜 费宇彤 李雨濛 靳昭晖 时晶.帕金森病100例中医证候特征分析[J].环球中医药,2017,10(09):1009.[doi:10.3969/j.issn.1674-1749.2017.09.022]
[5]张鑫,杨明会,李绍旦,等.补肾活血颗粒对帕金森病患者脑内神经递质多巴胺和5-羟色胺的影响[J].环球中医药,2012,5(10):729.
ZHANG Xin,YANG Ming hui,LI Shao dan,et al.Effects of Bushen Huoxue Granules on level of dopamine and 5hydroxytryptamine in early Parkinson’s disease patients[J].,2012,5(04):729.